Stock On High Alert

Questioning the Value of Recent Deals It seems like everyone's wearing rose-colored glasses when a fancy deal gets announced. But dig beneath the headlines, and you might find shareholders grumbling if firms like Penske Automotive Group, Accelerant Holdings, and Distribution Solutions Group are getting short-changed. The crux? Insiders making a pretty penny while ordinary...

Glenn Beck's Explosive Media Growth: A Paradigm Shift Well, would you look at that? Glenn Beck is grabbing eyeballs like nobody's business, and this isn't just a lucky streak. Since launching Torch earlier this year, Beck is practically on fire, setting new records left and right. Rattling the Giants: Beck vs. Rogan In the digital wild west that is YouTube, Beck has gone...

Game-Changing Results for Psoriatic Arthritis Surprising everyone this side of the stock ticker, Eli Lilly (NYSE: LLY) just announced their new data: pairing Taltz (ixekizumab) with Zepbound brought a clinical revolution for folks battling psoriatic arthritis and obesity. It's like finding gold under your mat—a combo punching PsA better than Taltz going solo. AT 52...

Shanghai and the Cultural Pulse of 2027 The 16th Shanghai Biennale is making some noise, and it's got a fitting title to match: LOUDER. Set to take the stage in November 2027, hosted by the Power Station of Art and curated by Ferran Barenblit, it's all about the soundtrack and visual kaleidoscope of our lives—a reminder that we're not just consumers of culture but...

Oxford Computer Group Strikes Again Another day, another nod from the big boys at Microsoft, eh? Oxford Computer Group, now part of MajorKey Technologies, hasn't just found themselves in the mix—they're standing tall as a finalist for not one but two significant categories in the 2026 Microsoft Partner of the Year Awards: Secure Access and Defense and Intelligence. You...

Navigating the Tennessee Real Estate Maze If you're talking about where the real estate action happens in Tennessee, you'd better mention Alyssa Bunch, the Vanderbilt-educated dynamo who turns the unforsale into the must-buy. Most of the deals she orchestrates are invisible to the public eye until they're all but written in ink and ready to reshape landscapes—or, more...

A Remarkable Milestone in Healthcare Leadership It's not every day someone hangs up their boots after 46 years of relentlessly steering the ship, especially in the tumultuous seas of healthcare. Come June 1, 2027, Lee Ann Stember plans to do just that as she retires as President & CEO of the National Council for Prescription Drug Programs (NCPDP). Her tenure is marked by...

Group 1 Tightens Its Grip on Lexus in Atlanta Let me tell you, consolidation in the auto world ain't anything new—this time, it's Group 1 Automotive's latest play in Atlanta. After sealing the deal on October 19, 2026, they scooped up Hennessy Lexus of Atlanta, dropping the 'Hennessy' and streamlining it under the new banner: Lexus of Atlanta. Fine, a bit typical as...

Launching into Vitiligo Treatment Trials I'll tell you, the biotech world isn't for the faint-hearted, especially when you're juggling hefty terms like 'TYK2/JAK1'. But here we are, watching Accro Bioscience and Fosun Pharma dive headlong into the vitiligo space with this Phase II/III trial of AC-201. They've bagged the IND clearance, and now the first patient is in the...

The Turbulence Behind FLNC: A Hard Pill to Swallow Looks like Fluence Energy (NASDAQ: FLNC) has stumbled right into a mess that's leaving investors with a bitter aftertaste. A securities class action lawsuit has been thrown their way, shaking up any stability folks thought they had. Levi & Korsinsky, LLP laid down the gauntlet on behalf of the shareholders hoodwinked by...